OSENI

NDC 64764-123 · Takeda Pharmaceuticals America, Inc.

Generic namealogliptin and pioglitazone

Dosage formTABLET, FILM COATED

RouteORAL

Active ingredient(s)ALOGLIPTIN BENZOATE, PIOGLITAZONE HYDROCHLORIDE

Strength12.5; 30 mg/1; mg/1

Pharmacologic classDipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA], Peroxisome Proliferator-activated Receptor gamma Agonists [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]

Marketing categoryNDA

Packages

64764-123-03 — 30 TABLET, FILM COATED in 1 BOTTLE (64764-123-03)

64764-123-04 — 90 TABLET, FILM COATED in 1 BOTTLE (64764-123-04)

64764-123-05 — 500 TABLET, FILM COATED in 1 BOTTLE (64764-123-05)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

57237-218 — Pioglitazone Hydrochloride and Metformin Hydrochloride, 57237-219 — Pioglitazone, 57237-220 — Pioglitazone, 57237-221 — Pioglitazone, 60687-391 — Pioglitazone, 60687-905 — Pioglitazone, 62135-804 — PIOGLITAZONE HYDROCHLORIDE, 62135-805 — PIOGLITAZONE HYDROCHLORIDE, 62135-806 — PIOGLITAZONE HYDROCHLORIDE, 63629-4946 — Alogliptin, 64764-125 — alogliptin, 64764-151 — pioglitazone, 64764-158 — pioglitazone and metformin hydrochloride, 64764-250 — alogliptin, 64764-251 — alogliptin and pioglitazone, 64764-253 — alogliptin and pioglitazone, 64764-254 — alogliptin and pioglitazone, 64764-301 — pioglitazone, 64764-302 — pioglitazone and glimepiride, 64764-304 — pioglitazone and glimepiride, +83 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels